Kevin Camphausen, MD
Enriched profileSenior Investigator and Chief, Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH · National Cancer Institute (NCI)
Kevin Camphausen is Senior Investigator and Chief, Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH at National Cancer Institute (NCI). OpenAlex indexes 654 publications with 19,536 citations (h-index 72); ClinicalTrials.gov lists 23 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Radiation Oncology profiles in the findmyKOL directory.
Data verified 17 Aug 2026
Overview
Updated 27 Aug 2026
Kevin Camphausen, MD, is Senior Investigator and Chief, Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH. The public record shows 654 publications with 19,536 citations (h-index 72), centered on Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Cancer, Hypoxia, and Metabolism. It also documents an investigator role on 23 registered clinical trials.
- Most recent indexed publication: 2026 · medRxiv
- Top research focus: Glioma Diagnosis and Treatment
- 23 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 243.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 23 registered studies on ClinicalTrials.gov. The most recent:
- Managing Cancer and Living Meaningfully (CALM) Therapy in Individuals Diagnosed With a Primary Brain Tumor
Sponsor: National Cancer Institute (NCI)
- Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
Sponsor: National Cancer Institute (NCI)
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 27 Aug 2026
120 congress contributions (2003–2026) across AACR, ASCO, ASH, ASTRO, SABCS per OpenAlex. The most recent:
- Abstract 2725: Grade-dependent survival and co-mutation landscapes in TP53-mutant gliomas: Biological insights and therapeutic implications.
AACR Annual Meeting
AACR2026Co-author - Abstract B040: Streamlining survival analysis with an automated machine learning pipeline: A case study in kidney renal clear cell carcinoma
AACR Annual Meeting
AACR2025Co-author - Abstract B032: Integrated genomic analysis defines early and late drivers of glioma evolution and survival outcome in GBM
San Antonio Breast Cancer Symposium
SABCS2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Inhibition of the Translation Initiation Factor eIF4A Enhances Tumor Cell Radiosensitivity.
Molecular cancer therapeutics
Article2022
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- ResearchGate
researchgate.net/scientific-contributions/Kevin-Camphausen-38172586
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
cancer.gov/rare-brain-spine-tumor/blog/2021/radiation-camphausen
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.gov ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →irp.nih.gov ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →irp.nih.gov ↗
- Board Certified in Radiation Oncology
American Board of Radiology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →irp.nih.gov ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →irp.nih.gov ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →eurekalert.org ↗
- Deputy Editor
Radiation Oncology (Springer/BioMed Central journal)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →link.springer.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.gov ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →videocast.nih.gov ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Stephen Chanock, MD
National Cancer Institute (NCI)
Seth Steinberg, PhD
National Cancer Institute (NCI)
Wyndham Wilson, MD
National Cancer Institute (NCI)